Clostridium toxin and method for preparing immunogenic compositions

Details for Australian Patent Application No. 2002301780 (hide)

Owner Institut Pasteur

Inventors Popoff, Michel-Robert; Gibert, Maryse

Agent Cullen & Co

Pub. Number AU-B-2002301780

Parent 91702

Filing date 1 November 2002

Wipo publication date 6 March 2003

Acceptance publication date 8 February 2007

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-B-2002301780

8 February 2007 Application Accepted

  Published as AU-B-2002301780

7 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301781-Solid pharmaceutical compositions for oral administration comprising itraconazole

2002301779-System for managing electrical power distribution